Vernon P Weygandt, CRNA Nurse Anesthetist, Certified Registered Medicare: Not Enrolled in Medicare Practice Location: 333 Hays Hill Dr, Fenton, MO 63026 Phone: 636-326-4716 |
Andrew Richardson, CRNA Nurse Anesthetist, Certified Registered Medicare: Accepting Medicare Assignments Practice Location: 1015 Bowles Ave, Fenton, MO 63026 Phone: 636-496-2000 |
Rebecca J Maul, CRNA Nurse Anesthetist, Certified Registered Medicare: Accepting Medicare Assignments Practice Location: 1015 Bowles Ave, Fenton, MO 63026 Phone: 314-775-2816 |
Lindsey N Bright, CRNA Nurse Anesthetist, Certified Registered Medicare: Accepting Medicare Assignments Practice Location: 1055 Bowles Ave, Fenton, MO 63026 Phone: 636-203-9700 |
Lawrence W Fournier Jr., CRNA Nurse Anesthetist, Certified Registered Medicare: Accepting Medicare Assignments Practice Location: 1015 Bowles Ave, Fenton, MO 63026 Phone: 314-775-2816 Fax: 314-775-2821 |
Kori A Stechmesser, CRNA Nurse Anesthetist, Certified Registered Medicare: Accepting Medicare Assignments Practice Location: 1015 Bowles Ave, Fenton, MO 63026 Phone: 314-775-2816 |
News Archive
People who have been exposed to chemical warfare agents (CWAs) feel uncertain, decades after the exposure, about their survival and ability to build a family, a University of Gothenburg study shows. Women are more severely affected than men.
​They keep tanning, even after turning a deep brown and experiencing some of the negative consequences. Skin cancer is among the most common, preventable types of the disease, yet many continue to tan to excess.
Scientists have long been worried about the possible harmful effects of regular cellular phone use, but so far no study has managed to produce clear results. Currently, cell phones are classified as carcinogenic category 2b - potentially carcinogenic to humans - by the International Agency for Research on Cancer (IARC).
Malaria, a disease caused mainly by the parasites Plasmodium falciparum and Plasmodium vivax, (P. vivax) is associated with over 400,000 deaths each year.
Bioniche Pharma, a leading developer and manufacturer of injectable pharmaceuticals, and Synerx Pharma, LLC announced today the FDA approval and launch of Isosulfan Blue Injection 1%.
› Verified 1 days ago